PARIS (France), 28 January 2009 - (HSMN NewsFeed) - Ipsen (Euronext:IPN) announced today that it has signed an agreement with Novartis for the co-promotion in France of the antihypertensive drug Exforge®. Already in partnership with Novartis since 2003…
Biopharmaceuticals
Ipsen, Novartis, Exforge, Nisis , Nisisco

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Ipsen announces the signature of a co-promotion agreement with Novartis for Exforge in France”
Leave a Comment